Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lexston Life Sciences Corp. (TSE:LEXT)
CNQX:LEXT
Lexston Life Sciences Corp. (LEXT) Stock Price & Analysis
3 Followers
LEXT Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.05 - C$0.13
Previous CloseC$0.07
Volume100.02K
Average Volume (3M)590.44K
Market Cap
C$2.68M
Enterprise ValueC$2.45M
Total Cash (Recent Filing)C$233.87K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta1.98
Next Earnings
Sep 23, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding30,309,167
10 Day Avg. Volume1,153,219
30 Day Avg. Volume590,444
Standard Deviation0.31
R-Squared0.02
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)5.74
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Lexston Life Sciences Corp. News
PremiumCompany Announcements
Lexston Addresses Unsanctioned Share Promotion
PremiumCompany Announcements
Lexston Kickstarts Uranium Exploration in Nunavut
PremiumCompany Announcements
Lexston Partners with Hillside for Marketing Push
PremiumCompany Announcements
Lexston Grants Stock Options to ConsultantsPremiumCompany Announcements
Lexston Life Sciences Upgrades to OTCQB Market
PremiumCompany Announcements
Lexston Mining Finalizes Oversubscribed Placement
PremiumCompany Announcements
Lexston Mining Seeks $400K in Private PlacementPremiumCompany Announcements
Lexston Advances in Dory Property with Share IssuanceOptions Prices
Currently, No data available
---
Ownership Overview
44.36% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
55.64% Public Companies and
Individual Investors
LEXT FAQ
What was Lexston Life Sciences Corp.’s price range in the past 12 months?
Lexston Life Sciences Corp. lowest stock price was C$0.05 and its highest was C$0.13 in the past 12 months.
What is Lexston Life Sciences Corp.’s market cap?
Currently, no data Available
When is Lexston Life Sciences Corp.’s upcoming earnings report date?
Lexston Life Sciences Corp.’s upcoming earnings report date is Sep 23, 2024 which is in 61 days.
How were Lexston Life Sciences Corp.’s earnings last quarter?
Lexston Life Sciences Corp. released its earnings results on Apr 04, 2024. The company reported -C$0.012 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.012.
Is Lexston Life Sciences Corp. overvalued?
According to Wall Street analysts Lexston Life Sciences Corp.’s price is currently Overvalued.
Does Lexston Life Sciences Corp. pay dividends?
Lexston Life Sciences Corp. does not currently pay dividends.
What is Lexston Life Sciences Corp.’s EPS estimate?
Lexston Life Sciences Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lexston Life Sciences Corp. have?
Lexston Life Sciences Corp. has 41,294,500 shares outstanding.
What happened to Lexston Life Sciences Corp.’s price movement after its last earnings report?
Lexston Life Sciences Corp. reported an EPS of -C$0.012 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 16.667%.
Which hedge fund is a major shareholder of Lexston Life Sciences Corp.?
Currently, no hedge funds are holding shares in TSE:LEXT
---
Lexston Life Sciences Corp. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.75%
12-Months-Change
Fundamentals
Return on Equity
-106.12%
Trailing 12-Months
Asset Growth
-46.89%
Trailing 12-Months
Company Description
Lexston Life Sciences Corp.
Lexston Life Sciences Corp is a biotechnology company providing cannabis testing and research services for the detection and screening of pathogens, analytical testing services for mid-stream cannabinoid potency and stability testing.
---
Technical Analysis
---